Home » Orchid Plans GDR Issue
Orchid Plans GDR Issue
Orchid Chemicals and Pharmaceuticals is planning a $100-million GDR (global depository receipt) issue to fund multitherapeutic expansion and also to pare interest burden. The GDR issue will have a greenshoe option of 15 percent. The board of directors, which met on Wednesday, cleared the GDR proposal. A shareholders' meeting will be held on July 18 to get their nod.
()a href="http://www.hindu.com/2005/06/16/stories/2005061605411900.htm" target="_blank">The Hindu
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May